A Randomised, Double-Blind, Parallel-Group Study Examining the Efficacy and Safety of Memantine in Patients With Moderate to Severe Dementia of the Alzheimer's Type.
Phase of Trial: Phase III
Latest Information Update: 04 Jun 2015
At a glance
- Drugs Memantine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors Lundbeck A/S
- 18 Jan 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 06 Jan 2012 Primary outcomes amended as reported by ClinicalTrials.gov.
- 15 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.